Regulatory delays and difficulties accessing private finance are holding back Europe’s green tech industry, entrepreneurs are warning. “It’s very difficult for companies to justify investing in Europe relative to the US,” said Ester Baiget, CEO of Danish biotech Novozymes, speaking at the annual EU Industry Days conference in Malaga last week.